ATS 2019 Virtual Final Program

1011 Moral Distress and Other Wellness Measures in Canadian Intensive Care Physicians/ P.M. Dodek, E. Cheung, K. Burns, C. Martin, P. Archambault, F. Lauzier, A. Sarti, A. Fox-Robichaud, A. Seely, A. Hamric, C.S. Parshuram, D. Garros, D. Wensley, D. Withington, D.J. Cook, D. Piquette, F. Carnevale, J.G. Boyd, G. Emeriaud, J. Downar, J. Rennick and the abstract also includes these names after D. Kutsogiannis, M. Dagenais, M. Chasse, P. Fontela, R. Fowler, S.M. Bagshaw, S. Dhanani, S. Murthy, T. Fujii, p.A4301 1012 Internal Medicine Resident Burnout: Effect of Time and Place/ E. Crossey, L. Oshima, J. Nakamatsu, M. As Sayaideh, J. Kagihara, R. Olds, G. Devendra, Honolulu, HI, p.A4302 1013 Moral Distress in Critical Care Physicians: Contextual and Relational Causes, Individual and Collective Consequences/ D. Piquette, F.A. Carnevale, K.E.A. Burns, A. Sarti, P.M. Dodek, Toronto, Canada, p.A4303 1014 Metrics of Ethics: How to Measure the Work and Build Medical Ethics Consultative Expertise to Support the ICU and Hospital/ M.H. Ieong, K. Seim, A. Cann, C. Fabrizi, Boston, MA, p.A4304 1015 The Feasibility of Introducing a Wellness Curriculum into a Pulmonary and Critical Care Medicine Fellowship Training Program/ S. Dua, R. Potter, New York, NY, p.A4305 1016 Improving Joy in the Workplace: Evaluation of a Multidisciplinary Intensive Care Unit (ICU) Follow-Up Conference to Improve Joy, Foster Community, and Lessen Burnout/ C. Townshend, B. Poole, J.W. Weiss, M.M. Hayes, Boston, MA, p.A4306 1017 Resilience Through Team Building: Cultivating a Culture of Connection in Academic Medicine/ K.A. McPherson, M. Tenney, K. Morrison, P. Kneeland, C. Lin, M. Moss, Aurora, CO, p.A7382 1018 Leadership Training in Pulmonary and Critical Care Fellowship: A National Survey of Program Directors/ T. Steinbach, R. Adamson, W.G. Carlos, J.L. Denson, P.A. Kritek, L. Santhosh, N. Seam, T.S. Wang, B. Coruh, Seattle, WA, p.A7383 CLINICAL POSTER DISCUSSION SESSION C22 ILD: DIAGNOSIS 9:15 a.m. - 11:15 a.m. KBHCCD Room C140/C142 (Level 1) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 Chairing: I. Glaspole, MBBS, PhD, Melbourne, Australia A.O. Adegunsoye, MD, Chicago, IL J. Morisset, MD, Montreal, Canada 101 Identification of Clinical Endotypes in Lymphangioleiomyomatosis to Improve Personalised Care/ S. Johnson, J.I. Johnson, N. Gupta, F.X. McCormack, J. Garibaldi, S. Chernbumroong, Nottingham, United Kingdom, p.A4307 102 Impact of Chest CT Quality on the Diagnosis of Usual Interstitial Pneumonia (UIP) Pattern: A Hub and Spoke Study/ G. Sgalla, A. Re, A. Farchione, G. Cicchetti, A.R. Larici, L. Calandriello, A. Comes, B. Iovene, F. Varone, R. Manfredi, L. Richeldi, Roma, Italy, p.A4308 103 Assessing the Clinical Utility of Serum Angiotensin-Converting Enzyme, Soluble IL-2 Receptor, and 1-25 Vitamin D in the Diagnosis of Extra-Pulmonary Sarcoidosis/ S. Gause, M.L. Ribeiro Neto, D.A. Culver, Cleveland, OH, p.A4309 104 Missed Opportunities for Diagnosis in Patients with Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study/ A.K. Gerke, A.C. Miller, P.M. Polgreen, Iowa City, IA, p.A4310 105 Algorithm for Pulmonary Hypertension Screening in Sarcoidosis: A Delphi Consensus/ L. Savale, M. Humbert, A. Wells, S.D. Nathan, R. Gupta, M. Huitema, X. Jaïs, J.C. Grutters, V. Kouranos, D. Montani, O.A. Shlobin, O. Sitbon, R.P. Baughman, Le Kremlin Bicêtre, France, p.A4311 106 Diagnostic Accuracy of 13N- Ammonia- and 18F-FDG-PET/cMRI in the Evaluation of Cardiac Sarcoidosis/ O. Sinokrot, L. Axel, R.M. Donnino, R. Condos, M.V. Ghesani, J.B. Alpert, New York, NY, p.A4312 107 Consistency of Automated Quantitation of Pulmonary Parenchymal Patterns on Normal, Low and Ultra-Low Dose CT/ C.M. Braun, C.W. Koo, F. Foley, E.M. Carmona Porquera, S. Kalra, G. Shaughnessy, A. Egan, R. Karwoski, T. Peikert, S. Rajagoplan, B.J. Bartholmai, J. Jacob, Rochester, MN, p.A4313 108 Impact of a Regional Multidisciplinary Conference on the Diagnosis of Interstitial Lung Disease/ J. Grewal, J. Morisset, J.H. Fisher, A.M. Churg, A.-M. Bilawich, J. Ellis, J. English, C.J. Hague, N. Khalil, J. Leipsic, J. Mayo, N.L. Muller, D. Murphy, J.L. Wright, C.J. Ryerson, Vancouver, Canada, p.A4314 109 Bronchoalveolar Lavage Fluid Cellular Analysis in Chronic Hypersensitivity Pneumonitis: A Systematic Review and Meta-Analysis/ C.J. Humphreys, N.A. Adderley, H. Barnes, B.J. Ley, D.J. Roberts, Z.A. Premji, K.A.M. Johannson, Calgary, Canada, p.A4315 110 Bronchoscopic Lung Biopsy for Diffuse Parenchymal Lung Disease: Comparison of Forceps with Cryobiopsy/ M. Koslow, E.S. Edell, T. Moua, A.C. Roden, E.S. Yi, P. Decker, J.H. Ryu, Rochester, MN, p.A4317 111 Peripheral Blood Gene Expression Profiling in the Multicenter IPF-PRO Registry Cohort/ I. Noth, R. Schmid, B. Strobel, G. Leparc, J. Roy, R. Vinisko, M. Neely, J.A. Belperio, C. Hesslinger, T. Leonard, S.M. Palmer, J.L. Todd, Charlottesville, VA, p.A4318 112 Pulmonary Imaging and Functional Abnormalities in an Undiagnosed Rheumatoid Arthritis Population/ A.J. Esposito, J.A. Sparks, H. Hatabu, E.A. Fletcher, S. Poli De Frias, M.L. Frits, C.K. Iannaccone, M. Prado, A. Zaccardelli, A. Marshall, P.F. Dellaripa, M.E. Weinblatt, N.A. Shadick, I.O. Rosas, T.J. Doyle, Boston, MA, p.A4319 ATS 2019 • Dallas, TX TUESDAY • MAY 21 231 TUESDAY MORNING